27 found
Order:
Disambiguations
Kathleen Cranley Glass [26]Kathleen C. Glass [1]
  1.  16
    Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths.Benjamin Freedman, Charles Weijer & Kathleen Cranley Glass - 1996 - Journal of Law, Medicine and Ethics 24 (3):243-251.
  2.  16
    Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory Myths.Benjamin Freedman, Kathleen Cranley Glass & Charles Weijer - 1996 - Journal of Law, Medicine and Ethics 24 (3):252-259.
  3.  3
    Placebo Orthodoxy in Clinical Research I: Empirical and Methodological Myths.Benjamin Freedman, Charles Weijer & Kathleen Cranley Glass - 1996 - Journal of Law, Medicine and Ethics 24 (3):243-251.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   18 citations  
  4.  5
    Placebo Orthodoxy in Clinical Research II: Ethical, Legal, and Regulatory Myths.Benjamin Freedman, Kathleen Cranley Glass & Charles Weijer - 1996 - Journal of Law, Medicine and Ethics 24 (3):252-259.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   15 citations  
  5.  38
    Clinical Equipoise and Not the Uncertainty Principle Is the Moral Underpinning of the Randomised Controlled Trial.Charles Weijer, Stanley H. Shapiro & Kathleen Cranley Glass - unknown
    Direct download  
    Translate
     
     
    Export citation  
     
    Bookmark   8 citations  
  6. Structuring the Review of Human Genetics Protocols.Kathleen Cranley Glass, Charles Weijer, Denis Cournoyer, Trudo Lemmens, Roberta M. Palmour, Stanley H. Shapiro & Benjamin Freedman - 1999 - IRB: Ethics & Human Research 21.
     
    Export citation  
     
    Bookmark  
  7.  17
    Monitoring Clinical Research: An Obligation Unfulfilled.Charles Weijer, Stanley Shapiro, Abraham Fuks, Kathleen Cranley Glass & Myriam Skrutkowska - unknown
    The revelation that data obtained for the US-based National Surgical Adjuvant Breast and Bowel Project (NSABP) from subjects enrolled at Hôpital Saint-Luc in Montreal was falsified has eroded public trust in research. Institutions can educate researchers and help prevent unethical research practices by establishing procedures to monitor research involving human subjects. Research monitoring encompasses four categories of activity: annual reviews of continuing research, monitoring of informed consent, monitoring of adherence to approved protocols and monitoring of the integrity of data. The (...)
    Direct download  
    Translate
     
     
    Export citation  
     
    Bookmark   6 citations  
  8.  21
    Incompetent Persons as Research Subjects and the Ethics of Minimal Risk.Kathleen Cranley Glass & Marc Speyer-Ofenberg - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):362.
    The voluntary and informed consent of subjects has been the central focus of concern in research reviews, overshadowing the importance of all other considerations. The Nuremberg Code, with its rights-based protection of the subject's autonomy above all else, made it difficult to justify research with no intended benefit when subjects are incompetent to make a valid informed choice to participate. Subsequent codes providing for research with incompetent subjects followed the lead of Nuremberg, substituting the informed authorization of a proxy for (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  9.  3
    The Physician/Investigator's Obligation to Patients Participating in Research: The Case of Placebo Controlled Trials.Kathleen Cranley Glass & Duff Waring - 2005 - Journal of Law, Medicine and Ethics 33 (3):575-585.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  10.  18
    Rethinking Risk in Pediatric Research.Kathleen Cranley Glass & Ariella Binik - 2008 - Journal of Law, Medicine and Ethics 36 (3):567-576.
    This article reviews four areas of pediatric research in which we have identified questionable levels of allowable risk, exceeding those foreseen by the Commission. They are the following: the categorization of increasingly risky interventions as minimal risk in a variety of protocols; the increasing number of applications for federal panel review of research not otherwise approvable because of higher projected risk levels; research on asymptomatic at risk children; and the inclusion of children and adolescents in placebo-controlled trials for participants of (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  11.  15
    Decisional Challenges for Children Requiring Assisted Ventilation at Home.Kathleen Cranley Glass & Franco A. Carnevale - 2006 - HEC Forum 18 (3):207-221.
  12.  46
    The Research Imperative Revisited Considerations for Advancing the Debate Surrounding Medical Research as Moral Imperative.Katherine Wayne & Kathleen Cranley Glass - 2010 - Perspectives in Biology and Medicine 53 (3):373-387.
    The continuous pursuit and support of medical research on both a societal and individual level is frequently presupposed as laudable, or even obligatory. However, some critics have challenged the assumption that medical research ought to be conducted. These critics reject claims that there is a moral obligation to pursue research, and that medical research may always be justifiable given adequate safeguards and regulations. We align ourselves with critics of the research imperative to the extent that we believe that medical research (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  13.  10
    The Physician/Investigator's Obligation to Patients Participating in Research: The Case of Placebo Controlled Trials.Kathleen Cranley Glass & Duff Waring - 2005 - Journal of Law, Medicine and Ethics 33 (3):575-585.
  14.  12
    Structuring the Review of Human Genetics Protocols Part II: Diagnostic and Screening Studies.Kathleen Cranley Glass, Charles Weijer, Trudo Lemmens, Roberta M. Palmour & Stanley H. Shapiro - forthcoming - IRB: Ethics & Human Research.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  15.  8
    Effective Trial Design Need Not Conflict with Good Patient Care.Kathleen Cranley Glass & Duff Waring - 2002 - American Journal of Bioethics 2 (2):25 – 26.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  16.  29
    Stem Cell Trials: Lessons From Gene Transfer Research.Jonathan Kimmelman, Françoise Baylis & Kathleen Cranley Glass - 2006 - Hastings Center Report 36 (1):23-26.
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  17.  12
    Toward a Duty to Report Clinical Trials Accurately: The Clinical Alert and Beyond.Kathleen Cranley Glass - 1994 - Journal of Law, Medicine and Ethics 22 (4):327-338.
  18.  3
    Toward a Duty to Report Clinical Trials Accurately: The Clinical Alert and Beyond.Kathleen Cranley Glass - 1994 - Journal of Law, Medicine and Ethics 22 (4):327-338.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  19.  31
    Describing Our “Humanness”: Can Genetic Science Alter What It Means to Be “Human”?Angela Campbell, Kathleen Cranley Glass & Louis C. Charland - 1998 - Science and Engineering Ethics 4 (4):413-426.
    Over the past several decades, geneticists have succeeded in identifying the genetic mutations associated with disease. New strategies for treatment, including gene transfer and gene therapy, are under development. Although genetic science has been welcomed for its potential to predict and treat disease, interventions may become ethically objectionable if they threaten to alter characteristics that are distinctively human. Before we can determine whether or not a genetic technique carries this risk, we must clarify what it means to be “human”. This (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  20.  6
    Structuring the Review of Human Genetics Protocols Part-III: Gene Therapy Studies.Kathleen C. Glass, Charles Weijer, Denis Cournoyer, Trudo Lemmens, Roberta M. Palmour, Stanley H. Shapiro & Benjamin Freedman - unknown
    Direct download  
    Translate
     
     
    Export citation  
     
    Bookmark   1 citation  
  21.  58
    LeRoy Walters and Julie Gage Palmer, the Ethics of Human Gene Therapy.Kathleen Cranley Glass - 1999 - Theoretical Medicine and Bioethics 20 (5):489-490.
  22.  4
    Structuring the Review of Human Genetics Protocols: Gene Localization and Identification Studies.Kathleen Cranley Glass, Charles Weijer, Roberta M. Palmour, Stanley H. Shapiro, Trudo M. Lemmens & Karen Lebacqz - unknown
    Direct download  
    Translate
     
     
    Export citation  
     
    Bookmark   1 citation  
  23.  46
    Protection of Human Subjects and Scientific Progress: Can the Two Be Reconciled?Kathleen Cranley Glass, David B. Resnik, Stephen Olufemi Sodeke, Halley S. Faust, Rebecca Dresser, Nancy M. P. King, C. D. Herrera, David Orentlicher & Lynn A. Jansen - 2006 - Hastings Center Report 36 (1):4-9.
  24.  7
    Weiss V. Solomon: A Case Study in Institutional Responsibility for Clinical Research.Benjamin Freedman & Kathleen Cranley Glass - 1990 - Journal of Law, Medicine and Ethics 18 (4):395-403.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  25.  8
    Weiss V. Solomon: A Case Study in Institutional Responsibility for Clinical Research.Benjamin Freedman & Kathleen Cranley Glass - 1990 - Journal of Law, Medicine and Ethics 18 (4):395-403.
  26.  3
    Reply to Dr. Ellen Burgess.Kathleen Cranley Glass - 1995 - Journal of Law, Medicine and Ethics 23 (2):212-212.
  27. Reply to Dr. Ellen Burgess.Kathleen Cranley Glass - 1995 - Journal of Law, Medicine and Ethics 23 (2):212-212.